Alzheimer's Disease Trial, Recruiting (NCT07064226)

Alzheimer's Disease Trial, Recruiting NCT07064226 Sponsor: Fondazione Don Carlo Gnocchi ETS Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07064226 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You scored above 17.79 on a standard memory and thinking test called the MoCA
You scored 1 or lower on a scale used to measure how much dementia affects daily life (called the CDR scale)
You have had more than 3 years of education
You are 65 years old or older
You are willing to take part and able to sign a consent form agreeing to join the study
You have a caregiver or trusted person (such as a family member or friend) who is able to support you during the trial
If you are taking memory medications called acetylcholinesterase inhibitors (such as donepezil or rivastigmine), your dose has been stable and unchanged for at least the past 3 months

Who may not be able to join:

You have problems with coordination, or significant difficulties with hearing, vision, or communication that would make it hard to take part in the trial
You are currently taking part in a rehabilitation program, or have done so in the 3 months before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Valeria Blasi, Medical Doctor, IRCCS Fondazione Don Carlo Gnocchi ONLUS

Phone: +390240308952

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07064226

Sponsor: Fondazione Don Carlo Gnocchi ETS

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: +390240308952

More information: https://clinicaltrials.gov/study/NCT07064226

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You scored above 17.79 on a standard memory and thinking test called the MoCA
You scored 1 or lower on a scale used to measure how much dementia affects daily life (called the CDR scale)
You have had more than 3 years of education
You are 65 years old or older
You are willing to take part and able to sign a consent form agreeing to join the study
You have a caregiver or trusted person (such as a family member or friend) who is able to support you during the trial
If you are taking memory medications called acetylcholinesterase inhibitors (such as donepezil or rivastigmine), your dose has been stable and unchanged for at least the past 3 months

Who may not be able to join:

You have problems with coordination, or significant difficulties with hearing, vision, or communication that would make it hard to take part in the trial
You are currently taking part in a rehabilitation program, or have done so in the 3 months before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Don Carlo Gnocchi ETS

Registry

ClinicalTrials.gov

Start date

6 October 2025

Est. completion

31 August 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in global cognitive functioning and subdomains measured by Montreal Cognitive Assessment MoCA; Change in Activation level of Patients measured by Patient Activation Measure 13 (PAM13)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov